Moreover, the patients with lymph node metastases (N1) had lower TRPV6 expression with a median RQ of 2.34 compared to patients without lymph node metastases (N0) with a median RQ of 0.54 (p = 0.0004) (Figure 7B). This evidence concerns the gene TRPV6 and metastatic malignant neoplasm in the lymph nodes.